Navigation Links
Professor Strauf's research is Nature Photonics’ cover article
Date:12/6/2007

HOBOKEN, N.J. Stefan Strauf, Assistant Professor in the Department of Physics & Engineering Physics at Stevens Institute of Technology, along with colleagues from the University of California, Santa Barbara and Leiden University (Netherlands), has authored the article, High-frequency single-photon source with polarization control, the cover article of the December 2007 issue of Nature Photonics (www.nature.com/nphoton/journal/v1/n12/abs/nphoton.2007.227.html).

The article reports on important advances in high-performance single-photon sources that bring such possibilities closer to reality. In particular, single photons can be used to implement absolutely secure optical communication, also known as Quantum Cryptography. With this new source, recording a single-photon signature that took eight hours five years back can now be achieved on a millisecond time scale. This remarkable progress was achieved by developing a novel type of microcavity structure which strongly enhances the light extraction from the optically active material. Moreover, with the help of embedded electrical gates, the researchers demonstrated suppression of unwanted dead-times in the emission process itself resulting in a net single photon generation rate of 100 MHz into an optical fiber.

As described in the News & Views section of the issue, More futuristic applications of single photon states include photonic networks designed to achieve scalable quantum computation, which one day will hopefully solve problems exponentially faster than classical computers.

Strauf also was interviewed by the publication regarding his work on the project. The traditional approach to generating single photons is to use weak laser pulses. In order to reach the single-photon level, you have to attenuate the light very strongly, limiting the efficiency of the device. Also, the photons emitted are governed by statistics. What we need is a high-efficiency source where we can generate photons one by one. Luckily, nature provides a solution in the form of the two-level system, just like the one we use: self-assembled quantum dots, said Strauf.


'/>"/>

Contact: Stephanie Mannino
smannino@stevens.edu
201-216-5602
Stevens Institute of Technology
Source:Eurekalert

Related biology technology :

1. Physics professor lauded for NSF efforts with prestigious award
2. Physics professor lauded for NSF efforts with prestigious award
3. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
4. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
5. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
6. Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
7. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):